Subscribe to RSS - Soleo Health

Soleo Health

Soleo Health launches alternative care paths program


FRISCO, Texas – Soleo Health has launched Soleo Direct, a program that aims to reduce unnecessary hospitalizations, readmissions and emergency room visits by identifying patients eligible to receive treatment at alternative sites of care.

Soleo Health to offer Xembify


FRISCO, Texas – Soleo Health has been selected by Grifols as a limited drug distribution partner for Xembify, which treats primary immunodeficiencies.

Soleo Health fills in footprint


MCKINNEY, Texas – Soleo Health has been focused on growing organically, but it’s now at a size where it makes sense to pursue tuck-in acquisitions, says CEO Drew Walk.

Soleo extends Midwest presence


MCKINNEY, Texas – Soleo Health has acquired the pharmacy business of Dayton, Ohio-based Paragon Infusion Therapy, which has a presence in southeast Ohio and throughout Indiana and Kentucky.

Soleo sees opportunity in data


MCKINNEY, Texas – Soleo Health has been on an aggressive growth path since its launch in 2014, adding locations and therapies, says CEO Drew Walk.

People news: Soleo Health, Pediatric Home Service


McKinney, Texas-based Soleo Health has appointed Craig Vollmer to the newly created role of chief commercial officer. Vollmer, who has been with Soleo Health since its founding in 2014, was promoted from executive vice president.

In brief: Insulet hits milestone, NCART launches MCO survey


ACTON, Mass. – Insulet Corp. has reported net income of $9.9 million for the fourth quarter of 2018 compared to a net loss of $6.9 million for the same period in 2017.

Double accreditation for Soleo Health


MCKINNEY, Texas – Soleo Health has announced two accreditations: Home Care Accreditation from The Joint Commission and Specialty Pharmacy Accreditation from URAC.

Short takes: Soleo, Freeus


McKinney, Texas-based Soleo Health has been chosen by Shire as a provider of the specialty drug VONVENDI, the first and only recombinant von Willebrand factor designed specifically for treating and managing adults with von Willebrand disease.

Soleo Health tapped to distribute two new drugs


MCKINNEY, Texas – Soleo Health has been selected by Genetech to dispense two limited distribution drugs, Hemlibra for patients with hemophilia A with factor VIII inhibitors; and Ocrevus for patients with a relapsing or primary progressive form of multiple sclerosis.